Patents by Inventor Devina Walter

Devina Walter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR REPROGRAMMING DISEASED MUSCULOSKELETAL CELLS
    Publication number: 20260097131
    Abstract: Disclosed herein are compositions and methods for reprogramming diseased musculoskeletal cells both in vitro and in vivo. In some embodiments, the disclosed method involves non-virally delivering intracellularly into the diseased musculoskeletal cells a polynucleotide comprising one or more nucleic acid sequences encoding one or more of the disclosed transcription factors.
    Type: Application
    Filed: December 11, 2025
    Publication date: April 9, 2026
    Inventors: Devina WALTER, Shirley TANG, Judith HOYLAND, Safdar KHAN, Benjamin WALTER, Daniel GALLEGO-PEREZ, Natalia HIGUITA-CASTRO
  • Compositions and methods for reprogramming diseased musculoskeletal cells
    Patent number: 12508325
    Abstract: Disclosed herein are compositions and methods for reprogramming diseased musculoskeletal cells both in vitro and in vivo. In some embodiments, the disclosed method involves non-virally delivering intracellularly into the diseased musculoskeletal cells a polynucleotide comprising one or more nucleic acid sequences encoding one or more of the disclosed transcription factors.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: December 30, 2025
    Assignees: Ohio State Innovation Foundation, UMIP The University of Manchester Intellectual Property
    Inventors: Devina Walter, Shirley Tang, Judith Hoyland, Safdar Khan, Benjamin Walter, Daniel Gallego-Perez, Natalia Higuita-Castro
  • COMPOSITIONS AND METHODS FOR REPROGRAMMING DISEASED MUSCULOSKELETAL CELLS
    Publication number: 20220118109
    Abstract: Disclosed herein are compositions and methods for reprogramming diseased musculoskeletal cells both in vitro and in vivo. In some embodiments, the disclosed method involves non-virally delivering intracellularly into the diseased musculoskeletal cells a polynucleotide comprising one or more nucleic acid sequences encoding one or more of the disclosed transcription factors.
    Type: Application
    Filed: December 19, 2019
    Publication date: April 21, 2022
    Inventors: Devina Walter, Shirley Tang, Judith Hoyland, Safdar Khan, Benjamin Walter, Daniel Gallego-Perez, Natalia Higuita-Castro